With someone diagnosed with cancer every 90 seconds in the UK¹, the need for transformative cancer care has never been more pressing. One healthcare provider answering this call is GenesisCare, the UK’s leading independent, specialist cancer care provider.
Operating 14 outpatient centres, including one in the heart of Milton Keynes, they’re providing innovative, personalised cancer treatments which can positively impact on patient quality of life, life expectancy and overall survival.
The CQC Good rated centre has also been awarded an esteemed Macmillan Quality Environment Mark, recognising and celebrating environments that meet the standards required by people living with cancer.
In 2023, the Milton Keynes centre marked a milestone with over a decade of service to cancer patients across Buckinghamshire and neighbouring regions. Including advanced imaging techniques, specialist clinics for breast and urology diagnosis, and precision radiotherapy for hard-to-reach tumours.
One treatment that’s changing patient outcomes is the state-of-the-art SABR radiotherapy, used for several adult cancers, including prostate, lung, pancreas, liver and kidney cancer. Stereotactic ablative radiotherapy (SABR) is a ground-breaking treatment which delivers targeted radiation with pinpoint precision, limiting damage to surrounding healthy tissue, and can be delivered in five sessions, compared to the traditional 15 to 35 sessions.
Every cancer and every person is unique, and GenesisCare believe a personalised approach to care and treatment, together with fast access is key to achieving the best possible outcomes.
At their centre in Milton Keynes, GenesisCare provide rapid access services, including appointments within 24 hours, same-day CT scans, a one-stop breast clinic, private breast screening and shorter treatment programmes with advanced radiotherapy, chemotherapy, and immunotherapy treatments also available.
Spotting cancer at the earliest possible stage is one of the most effective cancer interventions, and being diagnosed early often means more treatment options are available. According to data from the NHS, five-year survival for common and life-threatening cancers can be drastically improved by early diagnosis.²
“We are committed to ensuring our patients receive the cancer care they need without delay,” said Samantha Warman, Centre Leader at GenesisCare in Milton Keynes. “We’re also proud that we are developing relationships with a number of local Milton Keynes businesses to provide private breast screenings to their employees.”
Importantly, GenesisCare provide innovations which not only treat cancer but also practically and emotionally support those affected. These include the much-needed bra fitting and prosthetics service for breast cancer patients after surgery, and life-changing integrative cancer care, now widely considered as a key part of recovery and survivorship, combining treatment with emotional and lifestyle support.
At GenesisCare in Milton Keynes, cancer patients have access to specialist wellbeing support with the Penny Brohn UK Partnership. Penny Brohn has pioneered integrative cancer care in the UK, with one-to-one appointments wellbeing consultants who help tailor bespoke programmes of supportive therapies, including reflexology, acupuncture, relaxation training and counselling.
¹. Macmillan Cancer Support, 2022. Cancer statistics fact sheet: www.macmillan.org.uk/dfsmedia/1a6f2353 7f7f4519bb0cf14c45b2a629/9468-10061/2022-cancer-statistics-factsheet
². Cancer Research UK, 2023: Data from NHS Digital, 2022: www.cancerresearchuk.org/about-cancer/ cancer-symptoms/why-is-early-diagnosis-important/1000
To find out more information on services and treatments available from GenesisCare, call 0808 301 9753 or visit www.genesiscare.com/uk/our-centres/milton-keynes
